New Wave Of Clinical Trials May Throw Indian Regulators Off Balance - DIA Conference
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's ability to handle a growing number of clinical trial applications has reached a tipping point as ethics committees, regulators and other stakeholders struggle to meet demand which is expected to double in 2008, industry officials said